These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antinociceptive activity of intracisternally and intrathecally administered eptazocine, a novel analgesic, in mice. Aoki M; Kaneko S; Watanabe H Methods Find Exp Clin Pharmacol; 1990; 12(1):11-5. PubMed ID: 2314148 [TBL] [Abstract][Full Text] [Related]
6. [Pharmacological action of eptazocine (l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benz azonine). (V). A comparison of eptazocine, pentazocine and morphine with regard to ability of tolerance development after successive administration]. Nabeshima T; Yamada S; Kameyama T Nihon Yakurigaku Zasshi; 1986 Jun; 87(6):619-27. PubMed ID: 3744168 [TBL] [Abstract][Full Text] [Related]
7. The interaction of eptazocine, a novel analgesic, with opioid receptors. Nabeshima T; Matsuno K; Kamei H; Kameyama T Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):173-81. PubMed ID: 2992058 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacological action of eptazocine (l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benzazonine). (III) Central action of eptazocine (author's transl)]. Kameyama T; Nabeshima T; Yamaguchi K; Kamata K; Okuyama S; Tsuji H; Sakakibara S Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):629-45. PubMed ID: 7333566 [TBL] [Abstract][Full Text] [Related]
9. Effects of acutely administered analgesic drugs on rat brain 5-hydroxytryptamine turnover. Goodlet I; Sugrue MF Br J Pharmacol; 1972 Nov; 46(3):562P-563P. PubMed ID: 4656639 [No Abstract] [Full Text] [Related]
10. GM1 ganglioside counteracts selective neurotoxin-induced lesion of developing serotonin neurons in rat spinal cord. Fusco M; Donà M; Tessari F; Hallman H; Jonsson G; Gorio A J Neurosci Res; 1986; 15(4):467-79. PubMed ID: 3522923 [TBL] [Abstract][Full Text] [Related]
11. [Cardiohemodynamic and respiratory effects of eptazocine, a new analgesic agent, in anesthetized dogs]. Kimura T; Murakami H; Sakai H; Waki I Nihon Yakurigaku Zasshi; 1988 Mar; 91(3):151-61. PubMed ID: 3371799 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic/pharmacodynamic relationship of eptazocine, a narcotic-antagonist analgesic, in rats. Suzuki T; Shimizu R; Suganuma T; Nishino J; Tomono K; Hanano M; Watanabe J Biol Pharm Bull; 2000 Dec; 23(12):1504-10. PubMed ID: 11145186 [TBL] [Abstract][Full Text] [Related]
13. [Protective effect of eptazocine, a novel analgesic, against cerebral hypoxia-anoxia in mice]. Tamura T; Taniguchi T; Aoki M; Waki I Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):167-75. PubMed ID: 2370033 [TBL] [Abstract][Full Text] [Related]
14. Effects of d- and dl-chlorpheniramine on serotonin and 5-hydroxyindoleacetic acid levels in the regional parts of rat brain. Sakurai E; Yamasaki S; Hikichi N; Onodera K Yakubutsu Seishin Kodo; 1991 Aug; 11(4):237-44. PubMed ID: 1724716 [TBL] [Abstract][Full Text] [Related]
15. Central action of narcotic analgesics. VI. Further studies on the participation of serotonin in the action of analgesics. Malec D Pol J Pharmacol Pharm; 1980; 32(5):665-72. PubMed ID: 6115369 [TBL] [Abstract][Full Text] [Related]
16. [Analgesic and narcotic antagonist effects of buprenorphine (author's transl)]. Hiyama T; Shintani S; Tsutsui M; Yasuda Y Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):147-62. PubMed ID: 7084817 [TBL] [Abstract][Full Text] [Related]
17. Effects of eptazocine, a novel analgesic, on KCN-induced changes in the cerebral contents of glycolytic metabolites and high-energy phosphates in mice. Tamura T; Taniguchi T; Miyamoto T; Aoki M; Waki I Jpn J Pharmacol; 1990 Oct; 54(2):179-85. PubMed ID: 2077184 [TBL] [Abstract][Full Text] [Related]
18. [Protective effect of eptazocine, a novel analgesic, against cerebral ischemia in mice and rats]. Tamura T; Taniguchi T; Miyamoto T; Aoki M; Waki I Nihon Yakurigaku Zasshi; 1991 Feb; 97(2):65-74. PubMed ID: 2055580 [TBL] [Abstract][Full Text] [Related]
19. Central action of amitriptyline N-oxide. Maj J; Vetulani J; Michaluk J; Rogóz Z; Skuza G Pharmacopsychiatria; 1982 Nov; 15(6):187-91. PubMed ID: 6185962 [TBL] [Abstract][Full Text] [Related]
20. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]